Solid Biosciences SG&A Expense (Quarterly) Analysis

Solid Biosciences Inc (SLDB)

10.10 -0.13 (-1.27%) USD | NASDAQ | May 03, 16:00

10.18 +0.08 (+0.84%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	6.812M
September 30, 2023	6.412M
June 30, 2023	7.129M
March 31, 2023	7.399M
December 31, 2022	7.618M
September 30, 2022	7.127M
June 30, 2022	6.851M
March 31, 2022	7.352M
December 31, 2021	7.211M
September 30, 2021	7.143M
June 30, 2021	6.766M
March 31, 2021	6.015M
December 31, 2020	5.624M
September 30, 2020	5.181M
June 30, 2020	5.526M

Date	Value
March 31, 2020	5.25M
December 31, 2019	5.264M
September 30, 2019	6.925M
June 30, 2019	5.359M
March 31, 2019	7.033M
December 31, 2018	4.624M
September 30, 2018	4.47M
June 30, 2018	4.584M
March 31, 2018	4.044M
December 31, 2017	3.215M
September 30, 2017	3.077M
June 30, 2017	3.28M
March 31, 2017	5.38M
December 31, 2016	1.653M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

5.181M

Minimum

Sep 2020

7.618M

Maximum

Dec 2022

6.472M

Average

6.812M

Median

Dec 2023

SG&A Expense (Quarterly) Benchmarks